Question 1

What is Gyre Therapeutics, Inc.'s gyre pharmaceuticals — interest income expense net?

Accepted Answer

Gyre Therapeutics, Inc. (GYRE) reported gyre pharmaceuticals — interest income expense net of $252K in Q2 2026.

Question 2

How has Gyre Therapeutics, Inc.'s gyre pharmaceuticals — interest income expense net changed year-over-year?

Accepted Answer

Gyre Therapeutics, Inc.'s gyre pharmaceuticals — interest income expense net decreased by 7.0% year-over-year, from $271K to $252K.

Question 3

What does gyre pharmaceuticals — interest income expense net mean?

Accepted Answer

This represents the net balance of interest income earned and interest expense incurred by the business segment. It reflects the segment's financing structure and its ability to generate returns on cash balances versus the cost of its debt obligations. This metric is a key component of the segment's non-operating financial performance.

Line item	Three Months Ended June 30,	Six Months Ended June 30,
Total operating expenses	31,974	60,003
(Loss) income from operations	(2,240))	302)
Other (loss) income, net:
Interest income	941	1,797
Other expense, net	(488))	(301))
Change in fair value of warrant liability	212	2,467
(Loss) Income before income taxes	(1,575))	4,265)
Benefit (provision) for income taxes	(662)	(1,563))

Other segment segments

Similar metrics at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Gyre Therapeutics, Inc.'s gyre pharmaceuticals — interest income expense net.

Gyre Therapeutics, Inc. GYRE Gyre Pharmaceuticals — Interest Income Expense Net